世界のナノテクノロジードラッグデリバリー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nanotechnology Drug Delivery Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4013 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ナノテクノロジードラッグデリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ナノ結晶、ナノ粒子、リポソーム、ミセル、ナノチューブ、その他）、用途別市場規模（神経、腫瘍、循環器/生理、抗炎症/免疫、抗感染症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ナノテクノロジードラッグデリバリーの市場動向 ・企業の競争状況、市場シェア ・ナノテクノロジードラッグデリバリーの種類別市場規模（ナノ結晶、ナノ粒子、リポソーム、ミセル、ナノチューブ、その他） ・ナノテクノロジードラッグデリバリーの用途別市場規模（神経、腫瘍、循環器/生理、抗炎症/免疫、抗感染症、その他） ・ナノテクノロジードラッグデリバリーの北米市場規模2016-2027（アメリカ、カナダ） ・ナノテクノロジードラッグデリバリーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ナノテクノロジードラッグデリバリーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ナノテクノロジードラッグデリバリーの中南米市場規模2016-2027（メキシコ、ブラジル） ・ナノテクノロジードラッグデリバリーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie, Inc.、Amgen Inc.、Celgene Corporation、Johnson & Johnson、Merck & Co., Inc.、Novartis International AG、Perrigo Company plc、Pfizer, Inc.、Teva Pharmaceutical Industries Ltd.） ・結論

Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions.
Nanotechnology drug delivery is a growing field and is witnessing increasing acceptance in health care applications. Nanotechnology drug delivery is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. One important and active application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body.

Market Analysis and Insights: Global Nanotechnology Drug Delivery Market
The global Nanotechnology Drug Delivery market size is projected to reach US$ 9710.1 million by 2026, from US$ 5980.3 million in 2019, at a CAGR of 7.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanotechnology Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanotechnology Drug Delivery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanotechnology Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanotechnology Drug Delivery market.

Global Nanotechnology Drug Delivery Scope and Market Size
Nanotechnology Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanotechnology Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nanocrystals
Nanoparticles
Liposomes
Micelles
Nanotubes
Others

Segment by Application
Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Other Applications

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie, Inc.
Amgen Inc.
Celgene Corporation
Johnson & Johnson
Merck & Co., Inc.
Novartis International AG
Perrigo Company plc
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanotechnology Drug Delivery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nanocrystals
1.2.3 Nanoparticles
1.2.4 Liposomes
1.2.5 Micelles
1.2.6 Nanotubes
1.2.7 Others
1.3 Market by Application
1.3.1 Global Nanotechnology Drug Delivery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Neurology
1.3.3 Oncology
1.3.4 Cardiovascular/Physiology
1.3.5 Anti-inflammatory/Immunology
1.3.6 Anti-infective
1.3.7 Other Applications
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nanotechnology Drug Delivery Market Perspective (2016-2027)
2.2 Nanotechnology Drug Delivery Growth Trends by Regions
2.2.1 Nanotechnology Drug Delivery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanotechnology Drug Delivery Historic Market Share by Regions (2016-2021)
2.2.3 Nanotechnology Drug Delivery Forecasted Market Size by Regions (2022-2027)
2.3 Nanotechnology Drug Delivery Industry Dynamic
2.3.1 Nanotechnology Drug Delivery Market Trends
2.3.2 Nanotechnology Drug Delivery Market Drivers
2.3.3 Nanotechnology Drug Delivery Market Challenges
2.3.4 Nanotechnology Drug Delivery Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology Drug Delivery Players by Revenue
3.1.1 Global Top Nanotechnology Drug Delivery Players by Revenue (2016-2021)
3.1.2 Global Nanotechnology Drug Delivery Revenue Market Share by Players (2016-2021)
3.2 Global Nanotechnology Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanotechnology Drug Delivery Revenue
3.4 Global Nanotechnology Drug Delivery Market Concentration Ratio
3.4.1 Global Nanotechnology Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology Drug Delivery Revenue in 2020
3.5 Nanotechnology Drug Delivery Key Players Head office and Area Served
3.6 Key Players Nanotechnology Drug Delivery Product Solution and Service
3.7 Date of Enter into Nanotechnology Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nanotechnology Drug Delivery Breakdown Data by Type
4.1 Global Nanotechnology Drug Delivery Historic Market Size by Type (2016-2021)
4.2 Global Nanotechnology Drug Delivery Forecasted Market Size by Type (2022-2027)

5 Nanotechnology Drug Delivery Breakdown Data by Application
5.1 Global Nanotechnology Drug Delivery Historic Market Size by Application (2016-2021)
5.2 Global Nanotechnology Drug Delivery Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nanotechnology Drug Delivery Market Size (2016-2027)
6.2 North America Nanotechnology Drug Delivery Market Size by Type
6.2.1 North America Nanotechnology Drug Delivery Market Size by Type (2016-2021)
6.2.2 North America Nanotechnology Drug Delivery Market Size by Type (2022-2027)
6.2.3 North America Nanotechnology Drug Delivery Market Size by Type (2016-2027)
6.3 North America Nanotechnology Drug Delivery Market Size by Application
6.3.1 North America Nanotechnology Drug Delivery Market Size by Application (2016-2021)
6.3.2 North America Nanotechnology Drug Delivery Market Size by Application (2022-2027)
6.3.3 North America Nanotechnology Drug Delivery Market Size by Application (2016-2027)
6.4 North America Nanotechnology Drug Delivery Market Size by Country
6.4.1 North America Nanotechnology Drug Delivery Market Size by Country (2016-2021)
6.4.2 North America Nanotechnology Drug Delivery Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Nanotechnology Drug Delivery Market Size (2016-2027)
7.2 Europe Nanotechnology Drug Delivery Market Size by Type
7.2.1 Europe Nanotechnology Drug Delivery Market Size by Type (2016-2021)
7.2.2 Europe Nanotechnology Drug Delivery Market Size by Type (2022-2027)
7.2.3 Europe Nanotechnology Drug Delivery Market Size by Type (2016-2027)
7.3 Europe Nanotechnology Drug Delivery Market Size by Application
7.3.1 Europe Nanotechnology Drug Delivery Market Size by Application (2016-2021)
7.3.2 Europe Nanotechnology Drug Delivery Market Size by Application (2022-2027)
7.3.3 Europe Nanotechnology Drug Delivery Market Size by Application (2016-2027)
7.4 Europe Nanotechnology Drug Delivery Market Size by Country
7.4.1 Europe Nanotechnology Drug Delivery Market Size by Country (2016-2021)
7.4.2 Europe Nanotechnology Drug Delivery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology Drug Delivery Market Size (2016-2027)
8.2 Asia-Pacific Nanotechnology Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Nanotechnology Drug Delivery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanotechnology Drug Delivery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanotechnology Drug Delivery Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanotechnology Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Nanotechnology Drug Delivery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanotechnology Drug Delivery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanotechnology Drug Delivery Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanotechnology Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Nanotechnology Drug Delivery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanotechnology Drug Delivery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nanotechnology Drug Delivery Market Size (2016-2027)
9.2 Latin America Nanotechnology Drug Delivery Market Size by Type
9.2.1 Latin America Nanotechnology Drug Delivery Market Size by Type (2016-2021)
9.2.2 Latin America Nanotechnology Drug Delivery Market Size by Type (2022-2027)
9.2.3 Latin America Nanotechnology Drug Delivery Market Size by Type (2016-2027)
9.3 Latin America Nanotechnology Drug Delivery Market Size by Application
9.3.1 Latin America Nanotechnology Drug Delivery Market Size by Application (2016-2021)
9.3.2 Latin America Nanotechnology Drug Delivery Market Size by Application (2022-2027)
9.3.3 Latin America Nanotechnology Drug Delivery Market Size by Application (2016-2027)
9.4 Latin America Nanotechnology Drug Delivery Market Size by Country
9.4.1 Latin America Nanotechnology Drug Delivery Market Size by Country (2016-2021)
9.4.2 Latin America Nanotechnology Drug Delivery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology Drug Delivery Market Size (2016-2027)
10.2 Middle East & Africa Nanotechnology Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Nanotechnology Drug Delivery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanotechnology Drug Delivery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanotechnology Drug Delivery Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanotechnology Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Nanotechnology Drug Delivery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanotechnology Drug Delivery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanotechnology Drug Delivery Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanotechnology Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Nanotechnology Drug Delivery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanotechnology Drug Delivery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie, Inc.
11.1.1 AbbVie, Inc. Company Details
11.1.2 AbbVie, Inc. Business Overview
11.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Introduction
11.1.4 AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.1.5 AbbVie, Inc. Recent Development
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Details
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. Nanotechnology Drug Delivery Introduction
11.2.4 Amgen Inc. Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.2.5 Amgen Inc. Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Nanotechnology Drug Delivery Introduction
11.3.4 Celgene Corporation Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.3.5 Celgene Corporation Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Introduction
11.4.4 Johnson & Johnson Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Introduction
11.5.4 Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.5.5 Merck & Co., Inc. Recent Development
11.6 Novartis International AG
11.6.1 Novartis International AG Company Details
11.6.2 Novartis International AG Business Overview
11.6.3 Novartis International AG Nanotechnology Drug Delivery Introduction
11.6.4 Novartis International AG Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.6.5 Novartis International AG Recent Development
11.7 Perrigo Company plc
11.7.1 Perrigo Company plc Company Details
11.7.2 Perrigo Company plc Business Overview
11.7.3 Perrigo Company plc Nanotechnology Drug Delivery Introduction
11.7.4 Perrigo Company plc Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.7.5 Perrigo Company plc Recent Development
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Details
11.8.2 Pfizer, Inc. Business Overview
11.8.3 Pfizer, Inc. Nanotechnology Drug Delivery Introduction
11.8.4 Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.8.5 Pfizer, Inc. Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Details
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nanotechnology Drug Delivery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nanocrystals
Table 3. Key Players of Nanoparticles
Table 4. Key Players of Liposomes
Table 5. Key Players of Micelles
Table 6. Key Players of Nanotubes
Table 7. Key Players of Others
Table 8. Global Nanotechnology Drug Delivery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nanotechnology Drug Delivery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Nanotechnology Drug Delivery Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Nanotechnology Drug Delivery Market Share by Regions (2016-2021)
Table 12. Global Nanotechnology Drug Delivery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Nanotechnology Drug Delivery Market Share by Regions (2022-2027)
Table 14. Nanotechnology Drug Delivery Market Trends
Table 15. Nanotechnology Drug Delivery Market Drivers
Table 16. Nanotechnology Drug Delivery Market Challenges
Table 17. Nanotechnology Drug Delivery Market Restraints
Table 18. Global Nanotechnology Drug Delivery Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Nanotechnology Drug Delivery Market Share by Players (2016-2021)
Table 20. Global Top Nanotechnology Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology Drug Delivery as of 2020)
Table 21. Ranking of Global Top Nanotechnology Drug Delivery Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Nanotechnology Drug Delivery Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Nanotechnology Drug Delivery Product Solution and Service
Table 25. Date of Enter into Nanotechnology Drug Delivery Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nanotechnology Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Nanotechnology Drug Delivery Revenue Market Share by Type (2016-2021)
Table 29. Global Nanotechnology Drug Delivery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Nanotechnology Drug Delivery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Nanotechnology Drug Delivery Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Nanotechnology Drug Delivery Revenue Market Share by Application (2016-2021)
Table 33. Global Nanotechnology Drug Delivery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Nanotechnology Drug Delivery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Nanotechnology Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Nanotechnology Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Nanotechnology Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Nanotechnology Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Nanotechnology Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Nanotechnology Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Nanotechnology Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Nanotechnology Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Nanotechnology Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Nanotechnology Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Nanotechnology Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Nanotechnology Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nanotechnology Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Nanotechnology Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Nanotechnology Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Nanotechnology Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Nanotechnology Drug Delivery Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Nanotechnology Drug Delivery Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Nanotechnology Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Nanotechnology Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Nanotechnology Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Nanotechnology Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Nanotechnology Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Nanotechnology Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nanotechnology Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Nanotechnology Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Nanotechnology Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Nanotechnology Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Nanotechnology Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Nanotechnology Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 65. AbbVie, Inc. Company Details
Table 66. AbbVie, Inc. Business Overview
Table 67. AbbVie, Inc. Nanotechnology Drug Delivery Product
Table 68. AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 69. AbbVie, Inc. Recent Development
Table 70. Amgen Inc. Company Details
Table 71. Amgen Inc. Business Overview
Table 72. Amgen Inc. Nanotechnology Drug Delivery Product
Table 73. Amgen Inc. Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 74. Amgen Inc. Recent Development
Table 75. Celgene Corporation Company Details
Table 76. Celgene Corporation Business Overview
Table 77. Celgene Corporation Nanotechnology Drug Delivery Product
Table 78. Celgene Corporation Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 79. Celgene Corporation Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Nanotechnology Drug Delivery Product
Table 83. Johnson & Johnson Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 84. Johnson & Johnson Recent Development
Table 85. Merck & Co., Inc. Company Details
Table 86. Merck & Co., Inc. Business Overview
Table 87. Merck & Co., Inc. Nanotechnology Drug Delivery Product
Table 88. Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 89. Merck & Co., Inc. Recent Development
Table 90. Novartis International AG Company Details
Table 91. Novartis International AG Business Overview
Table 92. Novartis International AG Nanotechnology Drug Delivery Product
Table 93. Novartis International AG Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 94. Novartis International AG Recent Development
Table 95. Perrigo Company plc Company Details
Table 96. Perrigo Company plc Business Overview
Table 97. Perrigo Company plc Nanotechnology Drug Delivery Product
Table 98. Perrigo Company plc Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 99. Perrigo Company plc Recent Development
Table 100. Pfizer, Inc. Company Details
Table 101. Pfizer, Inc. Business Overview
Table 102. Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 103. Pfizer, Inc. Recent Development
Table 104. Teva Pharmaceutical Industries Ltd. Company Details
Table 105. Teva Pharmaceutical Industries Ltd. Business Overview
Table 106. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Product
Table 107. Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Business (2016-2021) & (US$ Million)
Table 108. Teva Pharmaceutical Industries Ltd. Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanotechnology Drug Delivery Market Share by Type: 2020 VS 2027
Figure 2. Nanocrystals Features
Figure 3. Nanoparticles Features
Figure 4. Liposomes Features
Figure 5. Micelles Features
Figure 6. Nanotubes Features
Figure 7. Others Features
Figure 8. Global Nanotechnology Drug Delivery Market Share by Application: 2020 VS 2027
Figure 9. Neurology Case Studies
Figure 10. Oncology Case Studies
Figure 11. Cardiovascular/Physiology Case Studies
Figure 12. Anti-inflammatory/Immunology Case Studies
Figure 13. Anti-infective Case Studies
Figure 14. Other Applications Case Studies
Figure 15. Nanotechnology Drug Delivery Report Years Considered
Figure 16. Global Nanotechnology Drug Delivery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Nanotechnology Drug Delivery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Nanotechnology Drug Delivery Market Share by Regions: 2020 VS 2027
Figure 19. Global Nanotechnology Drug Delivery Market Share by Regions (2022-2027)
Figure 20. Global Nanotechnology Drug Delivery Market Share by Players in 2020
Figure 21. Global Top Nanotechnology Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology Drug Delivery as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Nanotechnology Drug Delivery Revenue in 2020
Figure 23. Global Nanotechnology Drug Delivery Revenue Market Share by Type (2016-2021)
Figure 24. Global Nanotechnology Drug Delivery Revenue Market Share by Type (2022-2027)
Figure 25. North America Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Nanotechnology Drug Delivery Market Share by Type (2016-2027)
Figure 27. North America Nanotechnology Drug Delivery Market Share by Application (2016-2027)
Figure 28. North America Nanotechnology Drug Delivery Market Share by Country (2016-2027)
Figure 29. United States Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Nanotechnology Drug Delivery Market Share by Type (2016-2027)
Figure 33. Europe Nanotechnology Drug Delivery Market Share by Application (2016-2027)
Figure 34. Europe Nanotechnology Drug Delivery Market Share by Country (2016-2027)
Figure 35. Germany Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Nanotechnology Drug Delivery Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Nanotechnology Drug Delivery Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Nanotechnology Drug Delivery Market Share by Region (2016-2027)
Figure 45. China Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Nanotechnology Drug Delivery Market Share by Type (2016-2027)
Figure 53. Latin America Nanotechnology Drug Delivery Market Share by Application (2016-2027)
Figure 54. Latin America Nanotechnology Drug Delivery Market Share by Country (2016-2027)
Figure 55. Mexico Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Nanotechnology Drug Delivery Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Nanotechnology Drug Delivery Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Nanotechnology Drug Delivery Market Share by Country (2016-2027)
Figure 61. Turkey Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Nanotechnology Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. AbbVie, Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 65. Amgen Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 66. Celgene Corporation Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 68. Merck & Co., Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 69. Novartis International AG Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 70. Perrigo Company plc Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 71. Pfizer, Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 72. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nanotechnology Drug Delivery Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---